Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wardelmann

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 25, 2015
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reportingE Wardelmann, R L Haas, J V M G Bovée, et al.
Der Pathologe|August 17, 2010
[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"]A V Rüsseler, B Brors, T Fischer, et al.
Oncogene|October 30, 2013
SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcomaM Trautmann, E Sievers, S Aretz, et al.
Leukemia|July 1, 2017
An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemiaL Angenendt, S Reuter, D Kentrup, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>P G Casali, A Le Cesne, A P Velasco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkG D Demetri, C R Antonescu, B Bjerkehagen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational StudyA Bonetti, V L Le, Z I Carrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|December 25, 2015
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reportingE Wardelmann, R L Haas, J V M G Bovée, et al.
Der Pathologe|August 17, 2010
[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"]A V Rüsseler, B Brors, T Fischer, et al.
Oncogene|October 30, 2013
SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcomaM Trautmann, E Sievers, S Aretz, et al.
Leukemia|July 1, 2017
An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemiaL Angenendt, S Reuter, D Kentrup, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>P G Casali, A Le Cesne, A P Velasco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkG D Demetri, C R Antonescu, B Bjerkehagen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational StudyA Bonetti, V L Le, Z I Carrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Pageof 10